Gesco AG

  • WKN: A1K020
  • ISIN: DE000A1K0201
  • Land: Deutschland

Nachricht vom 11.05.2020 | 13:04

DGAP-DD: Gesco AG english


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
11.05.2020 / 13:03
The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title:
First name: Stefan
Last name(s): Heimöller

2. Reason for the notification

a) Position / status
Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
Gesco AG

b) LEI
529900OE7WBEDX7PVB49 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: DE000A1K0201

b) Nature of the transaction
Acquisition

c) Price(s) and volume(s)
Price(s) Volume(s)
15.8500 EUR 7655.55 EUR
15.9000 EUR 9667.20 EUR
16.0000 EUR 28384.00 EUR
16.0000 EUR 32.00 EUR
16.0000 EUR 3552.00 EUR
16.0000 EUR 752.00 EUR
16.1000 EUR 6601.00 EUR
16.1500 EUR 24225.00 EUR
16.1500 EUR 1453.50 EUR

d) Aggregated information
Price Aggregated volume
16.0285 EUR 82322.2500 EUR

e) Date of the transaction
2020-05-08; UTC+2

f) Place of the transaction
Name: XETRA
MIC: XETR



11.05.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

PSI Software AG

Original-Research: PSI AG (von First Berlin Equity Research GmbH): Hinzufügen

06. Dezember 2021